Comparison Chart Processa Pharmaceuticals, Inc.

Stocks

PCSA

US74275C4033

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 00:00:00 18/07/2026 +04			5-day change	1st Jan Change
2.310 ^USD	+3.12%		+6.94%	-19.79%

05-08	Processa Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-01	Processa Pharmaceuticals, Inc. Announces Transition of Employment Status of Sian Bigora, Chief Development and Regulatory Officer, Effective May 1, 2026	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	PROCESSA PHARMACEUTICALS, INC.	Bio Therapeutic Drugs	+3.12%	+6.94%	-19.79%	-56.62%	-99.93%	6.35M